Pediatric Neurology
Volume 32, Issue 4 , Pages 278-281, April 2005

Fatal neurologic involvement in pediatric Wegener’s granulomatosis

  • Tim Ulinski, MD

      Affiliations

    • Department of Pediatrics, Hôpital Edouard Herriot, Lyon, France
    • Corresponding Author InformationCommunications should be addressed to: Dr. Ulinski; Department of Pediatrics; Hôpital Edouard Herriot; 3, place d’Arsonval; 69437 Lyon Cedex 03; France
  • ,
  • Helene Martin, MD

      Affiliations

    • Department of Pediatrics, Hôpital Edouard Herriot, Lyon, France
  • ,
  • Brigitte Mac Gregor, MD

      Affiliations

    • Department of Pathology, Hôpital Edouard Herriot, Lyon, France
  • ,
  • Roger Dardelin, MD

      Affiliations

    • Department of Pediatrics, University Hospital Chambery, Chambery, France
  • ,
  • Pierre Cochat, PhD

      Affiliations

    • Department of Pediatrics, Hôpital Edouard Herriot, Lyon, France

Received 25 June 2004; accepted 21 October 2004. published online 07 March 2005.

Wegener’s granulomatosis is a potentially life-threatening vasculitis with widely variable presentation. Only three pediatric cases with severe central nervous system involvement are reported in the literature. Early fatal outcome as described here is exceptional. This report describes a 13-year-old female with typical skin lesions, proteinuria, and renal failure initially misdiagnosed as a Schoenlein-Henoch purpura. A kidney biopsy revealed severe extracapillary proliferation in 70% of the analyzed glomeruli but no granuloma. In spite of methylprednisolone pulse therapy and oral high-dose prednisone, end-stage renal failure was reached 4 months later, necessitating peritoneal dialysis. Three months later she presented with pulmonary hemorrhage and positive antineutrophil cytoplasmic antibodies suggesting Wegener’s granulomatosis. This episode was controlled by methylprednisolone pulses. Seven months later she presented generalized seizures and coma, suggesting central nervous system involvement confirmed by magnetic resonance imaging. Methylprednisolone pulses and intravenous immunoglobulins led to neurologic improvement. Oral methotrexate was then introduced for long-term disease control. Another severe relapse of central nervous system vasculitis did not respond to any applied therapies and led to death 16 months after initial symptoms. This case emphasizes the need for activity scores to identify patients at risk for progressive systemic vasculitis requiring early and long-term aggressive immunosuppressive therapy.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(04)00558-2

doi:10.1016/j.pediatrneurol.2004.10.008

Pediatric Neurology
Volume 32, Issue 4 , Pages 278-281, April 2005